tradingkey.logo

Palisade Bio Inc <PALI.OQ> expected to post a loss of 70 cents a share - Earnings Preview

ReutersMay 9, 2025 3:16 PM
  • Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Palisade Bio Inc is for a loss of 70 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 11.2% in the last three months. ​

  • Wall Street's median 12-month price target for Palisade Bio Inc is $14.00​, above​ its last closing price of $0.76. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.81

-1.99

-1.55

Beat

22.1

Sep. 30 2024

-3.37

-3.35

-2.32

Beat

30.8

Jun. 30 2024

-2.92

-2.93

-3.32

Missed

-13.3​

Mar. 31 2024

-4.80

-4.59

Beat

4.4

​​Dec. 31 2023

-5.17

-6.45

Missed

-24.6

Sep. 30 2023

-5.95

-5.91

-6.60

Missed

-11.7​

Jun. 30 2023

-6.79

-6.79

-7.95

Missed

-17

Mar. 31 2023

-10.86

-10.84

-8.10

Beat

25.3

This summary was machine generated May 9 at 15:16 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI